Global Steerable FNA Biopsy Needles Market Size By Type (Bone Cement Needle, Bone Biopsy Needle), By Application (Renal Biopsy, Liver Biopsy), By Region, And Segment Forecasts, 2023 to 2032

The Global Steerable FNA Biopsy Needles Market was valued at USD 312 million in 2023 and is projected to reach USD 567 million by 2031, growing at a CAGR of 7.9% during the forecast period from 2023 to 2031. The increasing prevalence of cancer and gastrointestinal disorders, rising demand for minimally invasive diagnostic procedures, and the growing adoption of advanced biopsy tools are propelling market growth. Steerable Fine Needle Aspiration (FNA) biopsy needles offer enhanced precision and flexibility, allowing physicians to obtain more accurate tissue samples from hard-to-reach lesions, significantly improving diagnostic outcomes.

Drivers:

1. Rising Incidence of Cancer and Chronic Diseases:

The global rise in cancer prevalence, especially pancreatic, lung, and gastrointestinal cancers, is intensifying the need for effective diagnostic tools like steerable FNA biopsy needles. These devices are vital for early detection, staging, and treatment planning.

2. Technological Advancements in Biopsy Devices:

Innovations in steerable needle design, including improved maneuverability, image-guidance compatibility, and reduced patient discomfort, are boosting adoption rates. Integration with real-time ultrasound and endoscopic ultrasound (EUS) systems further enhances diagnostic accuracy.

3. Increasing Preference for Minimally Invasive Procedures:

Healthcare systems worldwide are shifting towards minimally invasive diagnostic methods due to shorter recovery times, reduced procedural risks, and lower healthcare costs, directly supporting the uptake of FNA biopsy needles.

Restraints:

1. High Cost of Advanced Biopsy Equipment:

Steerable FNA biopsy systems often require high-end endoscopy or ultrasound platforms, making initial setup and maintenance costly, particularly in low- and middle-income countries.

2. Lack of Skilled Professionals:

Accurate use of steerable biopsy needles necessitates specialized training. A shortage of trained endosonographers and radiologists in certain regions may limit the market's expansion.

Opportunity:

1. Growing Demand in Emerging Markets:

Rapid improvements in healthcare infrastructure across Asia-Pacific, Latin America, and Africa are creating lucrative opportunities. Governments and private institutions in these regions are investing in diagnostic technologies to enhance early cancer detection.

2. Integration with Robotic and AI Platforms:

The incorporation of robotics and AI-guided navigation systems in biopsy procedures is paving the way for higher accuracy, better patient outcomes, and increased adoption of steerable biopsy devices in advanced care settings.

Market by System Type Insights:

In 2023, manual steerable FNA biopsy needles accounted for the largest share due to their affordability, reliability, and widespread use in routine procedures. However, robotically assisted biopsy needles are anticipated to witness the fastest growth during the forecast period, driven by rising demand for precision diagnostics and the integration of robotics in interventional radiology and oncology.

Market by End-Use Insights:

Hospitals dominated the market in 2023, contributing over 50% of the revenue. Their access to advanced diagnostic infrastructure and specialized personnel makes them primary users of steerable FNA biopsy tools. Ambulatory Surgical Centers (ASCs) are expected to exhibit the highest CAGR during the forecast period, supported by increasing outpatient procedures and rising preference for cost-effective diagnostic settings.

Market by Regional Insights:

North America led the global market in 2023, supported by high healthcare expenditure, early adoption of advanced medical technologies, and the strong presence of key market players. Asia-Pacific is projected to be the fastest-growing region due to growing awareness of early cancer screening, rising disposable incomes, and rapid healthcare modernization in countries like China and India.

Competitive Scenario:

Key players in the Global Steerable FNA Biopsy Needles Market include Olympus Corporation, Medtronic plc, Cook Medical LLC, Boston Scientific Corporation, CONMED Corporation, Becton, Dickinson and Company (BD), Hologic Inc., and Medline Industries LP. These companies are focusing on new product development, strategic collaborations, and regional expansions.

In 2023, Olympus Corporation launched a next-gen EUS-guided steerable biopsy needle with enhanced visualization capabilities.

In 2024, Boston Scientific acquired a diagnostics startup to boost its FNA biopsy product pipeline with AI-enhanced targeting algorithms.

Cook Medical expanded its production capacity in 2025 to meet the growing global demand for steerable biopsy tools in oncology diagnostics.

Scope of Work – Global Steerable FNA Biopsy Needles Market

Report Metric Details

Market Size (2023) USD 312 million

Projected Market Size (2031) USD 567 million

CAGR (2023–2031) 7.9%

Market Segments By System Type, End-use, Region

Growth Drivers Rising cancer prevalence, Minimally invasive diagnostics, Technological innovation

Opportunities Emerging markets, AI & robotic integration

Key Market Developments:

2023: Olympus introduced a next-gen steerable needle compatible with enhanced EUS systems, improving lesion targeting.

2024: Medtronic launched a compact, portable biopsy platform aimed at low-resource settings in Latin America.

2025: Boston Scientific partnered with a leading AI diagnostics firm to integrate machine learning into its FNA biopsy system.

FAQs:

1) What is the current market size of the Global Steerable FNA Biopsy Needles Market?

The market was valued at USD 312 million in 2023.

2) What is the major growth driver of the Global Steerable FNA Biopsy Needles Market?

Rising prevalence of cancer and the growing demand for minimally invasive diagnostic procedures are key growth drivers.

3) Which is the largest region during the forecast period in the Global Steerable FNA Biopsy Needles Market?

North America is the largest region due to advanced healthcare systems and early adoption of biopsy technologies.

4) Which segment accounted for the largest market share in the Global Steerable FNA Biopsy Needles Market?

The manual steerable biopsy needles segment held the largest share in 2023.

5) Who are the key market players in the Global Steerable FNA Biopsy Needles Market?

Key players include Olympus Corporation, Medtronic plc, Cook Medical, Boston Scientific Corporation, and Becton, Dickinson and Company.